Insiderslab.com announced the latest insider trading report for Gilead Sciences (NASDAQ:GILD).
New York, NY -- (SBWIRE) -- 01/07/2014 -- Today, Insiderslab.com announced the latest insider trading report for Gilead Sciences (NASDAQ:GILD). US stock investors can access these reports through the links below, including stock performance, insider trading signals, and visual results.
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Gilead Sciences, Inc. (NASDAQ:GILD): By the end of last trading session, the shares of Gilead Sciences (NASDAQ:GILD) lost 1.45% (or US$1.08) to US$73.24 with 8.35 million shares exchanged hands, compared to daily average volume of 10.97 million. Compare to the industry of Biotechnology dropped 0.50%, its competitor Pfizer Inc. (PFE) raised 0.10% to US$30.55. Insiderslab.com found company Chairman and CEO, John C. Martin, sold his shares at the price of US$75.02 for about US$10.55 million on January 2. Within the same day, the company’s CFO Robin L. Washington and EVP Gregg H. Alton sold their shares for huge volume. Investors may want to find out how Gilead Sciences insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for GILD here.
Exclusive Report: http://www.insiderslab.com/PR3/010714A/GILD/GileadSciences
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)